Table 1.
Term | Technique | Ref. | |||||||
---|---|---|---|---|---|---|---|---|---|
DTU (current nomenclature) | I | II | III | IV | V | VI | [31] | ||
SL-IR, 24Sα rRNA, 18S rRNA, Cytb, Histone H2B, ITS1 rDNA, 18S rRNA, gGAPDH | TcBat | [32–34] | |||||||
Putative intra-TcI subdivisions | SL-IR | Ia, Ib, Ic, Id, Ie | [48–51] | ||||||
MLMT, mtMLST | IDOM | [52,53,70] | |||||||
DTU† | MLEE, RAPD, 24Sα rRNA, 18S rRNA | I | IIb | IIc | IIa | IId | IIe | [45,46] | |
Zymodeme | MLEE | ZI | ZII | ZIII/ZI ASAT | ZIII | Bolivian ZII | Paraguayan ZII | [16,36,37,128,290–292] | |
MLEE | ZB | ZA | ZC | ZD | ZB | ZB | [293,294] | ||
MLEE | Z2, 5, 7, 10 or 12 | Z4 or 11 | Z1, 3 or 9 | [295] | |||||
ITS-RFLP, 24Sα rRNA | ZIII-A | ZIII-B | [296] | ||||||
Biodemes | MLEE | III | II | I | I | [171] | |||
Clonet | MLEE | 1–25 | 30–34 | 35–37 | 27–29 | 38, 39 | 40–43 | [38] | |
Trypanosoma cruzi | T. cruzi I | T. cruzi II | T. cruzi | T. cruzi | T. cruzi | T. cruzi | [44] | ||
Lineage | 24Sα rRNA, SL-IR, RAPD | 2 | 1 | 1/2 | 1/2 | [41] | |||
24Sα rRNA, SL-IR | 2 | 1 | 2′ | 2′ | 1 | 1 | [42,43] | ||
Clade | TR, DHFR-TS, COII-ND1 | A | C | B | D | B + C | B + C | [60] | |
Riboclades | 24Sα rRNA, 18S rRNA | 2 | 1 | 3 | 4 | 3 | 1 | [297] | |
Haplogroups | MLMT, 24Sα rRNA, COII, ND1, Cytb | ZZ | YY | XX | XY | XY | [54] | ||
TcMSH2 | A | C | B | [298] | |||||
Group | Karyotyping | C | B | D | A | A | [154] | ||
SL-IR | II | I | I | I | I | [299] | |||
Reference strain | Sylvio X10/1 | Esm cl3 | M5631 cl5 | CanIII cl1 | Sc43 cl1 | CL Brener |
†Proposed by [47].
DHFR-TS: Dihydrofolate reductase-thymidylate synthase; gGAPDH: Glyceraldehyde 3-phosphate dehydrogenase; MLEE: Multilocus enzyme electrophoresis; MLMT: Multilocus microsatellite typing; mtMLST: Maxicircle multilocus sequence typing; RAPD: Random amplification of polymorphic DNA; RFLP: Restriction fragment length polymorphism; SL-IR: Spliced-leader intergenic region; TR: Trypanothione reductase.